AdvanSix ASIX 深 滬
等待開盤 09-23 09:30:00 美东时间
16.72
+0.470
+2.89%
華盛通- 最 高16.775
- 今 開16.28
- 成交量 24.38万股
- 最 低 16.20
- 昨 收 16.25
- 總市值 4.51亿
- 52周最高 26.41
- 市盈率 靜 9.27
- 換手率 0.90%
- 52周最低 13.62
- 委 比 50.00%
- 總股本 2700.12万
- 歷史最高 54.315
- 量 比 0.76
- 振 幅 3.54%
- 歷史最低 5.025
- 每 手 1
- 風險率 2.73%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多全球尼龙产业链迎涨价潮
（来源：中化新网） 8月17日，化工巨头巴斯夫在其官网发布通知，宣布自9月1日起在北美地区提高己内酰胺、尼龙6及共聚酰胺6/66的价格，涨幅为每磅8美分。这...
08-24 18:20
AdvanSix Restructures Credit Facilities to Enhance Liquidity
AdvanSix ( ($ASIX) ) has provided an announcement. On August 14, 2026, AdvanSix...
08-18 04:48
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
Truist Securities Maintains Hold on AdvanSix, Lowers Price Target to $18
Truist Securities analyst Peter Osterland maintains AdvanSix (NYSE:ASIX) with a Hold and lowers the price target from $20 to $18.
08-11 01:31
AdvanSix declares $0.16 dividend
AdvanSix (ASIX) declares $0.16/share quarterly dividend, in line with previous. Forward yield 3.89% Payable Sept. 1; for shareholders of record Aug. 18; ex-div Aug. 18. See ASIX Dividend Scorecard, Yi...
08-08 00:54
AdvanSix shares are trading lower after the company reported worse-than-expected Q2 financial results.
AdvanSix shares are trading lower after the company reported worse-than-expected Q2 financial results.
08-07 19:50
AdvanSix Q2 Adj. EPS $0.19 Misses $0.56 Estimate, Sales $421.284M Miss $452.150M Estimate
AdvanSix (NYSE:ASIX) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $0.56 by 66.07 percent. This is a 84.68 percent decrease over earnings of $1.24 per share from the same period last year. The company reported quarterly sales of $421.284 million which ...
08-07 18:31
AdvanSix 2026年第二季度财报：销售额增长但植物营养业务拖累利润
AdvanSix 2026年第二季度销售额增长3%至4.213亿美元，主要得益于18%的有利定价抵消了15%的销量下滑。摊薄后每股收益从1.15美元降至0.12美元，而调整后EBITDA下降43%至3190万美元，利润率收窄至7.6%。植物营养业务销量下降、产量减少以及税率上升令盈利承压。经营活动现金流降至1000万美元，自由现金流为负1070万美元。公司重申2026年资本支出指引为7500万至9500万美元，并预计下半年现金流将有所改善。
08-07 10:45
AdvanSix shares are trading lower after the company reported worse-than-expected Q1 adjusted EPS results.
AdvanSix shares are trading lower after the company reported worse-than-expecte...
05-08 23:41
